85 related articles for article (PubMed ID: 21169412)
1. Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone.
Lilly AJ; Khanim FL; Hayden RE; Luong QT; Drayson MT; Bunce CM
Cancer Res; 2011 Feb; 71(3):1177-86. PubMed ID: 21169412
[TBL] [Abstract][Full Text] [Related]
2. [Expression of nm23 genes in acute myeloid leukemia and its clinical significance].
Meng QX; Jiang R; Yang BQ; Zhang HY; Liu J; Pang LP; Wang J
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):369-71. PubMed ID: 12941193
[TBL] [Abstract][Full Text] [Related]
3. Nm23-H1 regulates the proliferation and differentiation of the human chronic myeloid leukemia K562 cell line: a functional proteomics study.
Jin L; Liu G; Zhang CH; Lu CH; Xiong S; Zhang MY; Liu QY; Ge F; He QY; Kitazato K; Kobayashi N; Wang YF
Life Sci; 2009 Mar; 84(13-14):458-67. PubMed ID: 19302816
[TBL] [Abstract][Full Text] [Related]
4. Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells.
Okabe-Kado J; Kasukabe T; Honma Y; Kobayashi H; Maseki N; Kaneko Y
Cancer Sci; 2009 Oct; 100(10):1885-94. PubMed ID: 19664043
[TBL] [Abstract][Full Text] [Related]
5. The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression.
Lilly AJ; Khanim FL; Bunce CM
Naunyn Schmiedebergs Arch Pharmacol; 2015 Feb; 388(2):225-33. PubMed ID: 25119778
[TBL] [Abstract][Full Text] [Related]
6. Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.
Okabe-Kado J; Kasukabe T; Honma Y; Kobayashi H; Maseki N; Kaneko Y
Int J Hematol; 2009 Sep; 90(2):143-152. PubMed ID: 19655221
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
8. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
9. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
[TBL] [Abstract][Full Text] [Related]
10. Nm23-H1 promotes adhesion of CAL 27 cells in vitro.
Bago R; Pavelić J; Maravić Vlahovicek G; Bosnar MH
Mol Carcinog; 2009 Sep; 48(9):779-89. PubMed ID: 19263457
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
[TBL] [Abstract][Full Text] [Related]
12. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
13. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
15. Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells.
de Jonge-Peeters SD; van der Weide K; Kuipers F; Sluiter WJ; de Vries EG; Vellenga E
Ann Hematol; 2009 Jun; 88(6):573-80. PubMed ID: 19002460
[TBL] [Abstract][Full Text] [Related]
16. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
Okabe-Kado J
Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
Ouatas T; Halverson D; Steeg PS
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
[TBL] [Abstract][Full Text] [Related]
19. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
